BPTH On Steady Path, Cancer Genetics On Watch, GLPG/GILD Scrap IPF Drug, REGN s Libtayo Gets FDA Nod
Read on.
1. Bio-Path On A Steady Path
Bio-Path Holdings Inc. (BPTH) has been granted the third U.S. patent, expanding the protection of its DNAbilize platform technology that helps to deliver DNA therapeutics directly to cancer cells.
In addition, the company is expected to be issued a patent related to its lead product candidate, Prexigebersen, in combination with either a cytidine analogue, such as decitabine, or the Bcr-Abl tyrosine kinase inhibitors dasatinib and nilotinib, on February 23, 2021.
Prexigebersen is in a Phase 2 study for blood cancers and Prexigebersen-A, a drug product modification of Prexigebersen, is under consideration by the FDA to commence Phase 1 studies in solid tumors.
Share:
Usana Health Sciences (NYSE: USNA) shares are trading higher after the company reported better-than-expected Q4 EPS and sales results and issued fiscal year 2021 EPS and sales guidance above estimates. The company also announced a $150 million buyback.
Usana Health Sciences is a U.S.-based company engaged in developing, manufacturing, and selling science-based nutritional and personal-care products.
Usana Health Sciences shares were trading up 10.20% at $96.05 at the time of publication. The stock has a 52-week high of $101.50 and a 52-week low of $43.01.
AzurRx BioPharma (NASDAQ: AZRX) shares are trading higher after HC Wainwright & Co maintained its Buy rating on the stock and raised its price target from $2 to $3.50 per share.
Geographically, the following regions together with the listed national/local markets are fully investigated:
APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)
North America (U.S., Canada, and Mexico)
South America (Brazil, Chile, Argentina, Rest of South America)
MEA (Saudi Arabia, UAE, South Africa) For each aforementioned region and country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of all regional markets by country and split of key national markets by Service, Technology, and Application over the forecast years are also included.
88 Biggest Movers From Friday Benzinga 2/1/2021
Gainers
Siebert Financial Corp. (NASDAQ: SIEB) shares climbed 121.6% to close at $8.22 on Friday on heavy volume.
Catabasis Pharmaceuticals, Inc. (NASDAQ: CATB) climbed 70.8% to close at $4.15 after the company announced the acquisition of Quellis Biosciences.
GameStop Corp. (NYSE: GME) shares added 67.9% to close at $325.00 after Robinhood said it would allow some buying of the stocks on Friday after sparking outrage over discontinuing purchases of GME, AMC, and high stocks seeing social media interest. The company’s stock dropped over 44% on Thursday.
Novavax, Inc. (NASDAQ: NVAX) surged 64.9% to close at $220.94 after the company said Thursday that its COVID-19 vaccine candidate NVX-COV2373 showed 89.3% efficacy in Phase 3 trials conducted in the United Kingdom.